Congenital disorders of glycosylation are a genetically and clinically heterogeneous group
of> 130 diseases caused by defects in various steps along glycan modification pathways …

Abstract d‐Mannose is a C‐2 epimer of d‐glucose, which is a natural monosaccharide. It
can be obtained from both plants and microorganisms. Chemical synthesis and …

Abstract d-mannose, a C-2 epimer of glucose, exists naturally in many plants and fruits, and
is found in human blood at concentrations less than one-fiftieth of that of glucose. However …

Idiopathic non-cirrhotic portal hypertension (INCPH) is a clinicopathologic disease entity
characterized by the presence of clinical signs and symptoms of portal hypertension (PH) in …

Congenital disorders of glycosylation (CDG) are a group of clinically and genetically
heterogeneous metabolic disorders. Over 150 CDG types have been described. Most CDG …

Congenital disorders of glycosylation comprise most of the nearly 70 genetic disorders
known to be caused by impaired synthesis of glycoconjugates. The effects are expressed in …

Congenital (genetic) disorders of glycosylation (CDG) are a rapidly growing disease family,
with some 45 members reported since its first clinical description in 1980. Most of these are …

In Japan, bezafibrate (BF) is a second‐line agent for primary biliary cholangitis (PBC) that is
refractory to ursodeoxycholic acid (UDCA) treatment. From a retrospective cohort (n= 873) …

Idiopathic non-cirrhotic portal hypertension (INCPH) is a rare disease characterized of
intrahepatic portal hypertension in the absence of cirrhosis or other causes of liver disease …

Congenital disorders of glycosylation (CDG) are a rapidly growing family of genetic diseases
caused by defects in glycosylation. Nearly 100 CDG types are known so far. Patients present …